EDGC has announced that they achieved meaningful results at MEDLAB 2019 in Dubai.

MEDLAB, the world's largest medical laboratory exhibition centered on the middle east and Africa region, welcomed over 20,000 participants from more than 670 companies in 50 countries.

In this MEDLAB, EDGC consulted about a contract for personalized services based on genome analysis such as GENE2ME PLUS, TELOAGE, etc. Also, lively discussions took place for technology transfer of self-developed clinical services such as NICE, LIQUID BIOPSY, etc.

"Through this year's MEDLAB, we've strengthened cooperative relationships with existing partners by drawing expansion of the service. In addition, we will make increasing revenue in the middle east region as we focus on sales and marketing capabilities for over 200 new customers," Jay You, a vice president of EDGC, evaluated.

Additionally, "We will expand global services on genomic analysis and diseases prediction test by forging a new partnership at ASCO(American Society of Clinical Oncology) and BIO USA(BIO International Convention) expected to open on June," he announced.